These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 27266227)

  • 21. Comparison of Diagnostic Performance of Three-Dimensional Positron Emission Mammography versus Whole Body Positron Emission Tomography in Breast Cancer.
    Dai D; Song X; Wang M; Li L; Ma W; Xu W; Ma Y; Liu J; Zhang J; Liu P; Gu X; Su Y
    Contrast Media Mol Imaging; 2017; 2017():5438395. PubMed ID: 29097927
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic performance of dedicated positron emission mammography using fluorine-18-fluorodeoxyglucose in women with suspicious breast lesions: a meta-analysis.
    Caldarella C; Treglia G; Giordano A
    Clin Breast Cancer; 2014 Aug; 14(4):241-8. PubMed ID: 24472718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
    Rosen EL; Turkington TG; Soo MS; Baker JA; Coleman RE
    Radiology; 2005 Feb; 234(2):527-34. PubMed ID: 15671006
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The potential role of positron emission mammography for detection of breast cancer. A phantom study.
    Raylman RR; Majewski S; Wojcik R; Weisenberger AG; Kross B; Popov V; Bishop HA
    Med Phys; 2000 Aug; 27(8):1943-54. PubMed ID: 10984240
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the Response to Breast Cancer Neoadjuvant Chemotherapy Using 18F-FDG Positron Emission Mammography Compared With Whole-Body 18F-FDG PET: A Prospective Observational Study.
    Noritake M; Narui K; Kaneta T; Sugae S; Sakamaki K; Inoue T; Ishikawa T
    Clin Nucl Med; 2017 Mar; 42(3):169-175. PubMed ID: 28072617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretation of positron emission mammography and MRI by experienced breast imaging radiologists: performance and observer reproducibility.
    Narayanan D; Madsen KS; Kalinyak JE; Berg WA
    AJR Am J Roentgenol; 2011 Apr; 196(4):971-81. PubMed ID: 21427351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative analysis of imaging sensitivity of positron emission mammography and whole-body PET in relation to tumor size.
    Yamamoto Y; Ozawa Y; Kubouchi K; Nakamura S; Nakajima Y; Inoue T
    Clin Nucl Med; 2015 Jan; 40(1):21-5. PubMed ID: 25423346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Positron emission mammography (PEM): reviewing standardized semiquantitative method.
    Yamamoto Y; Tasaki Y; Kuwada Y; Ozawa Y; Katayama A; Kanemaki Y; Enokido K; Nakamura S; Kubouchi K; Morita S; Noritake M; Nakajima Y; Inoue T
    Ann Nucl Med; 2013 Nov; 27(9):795-801. PubMed ID: 23818008
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiologist views of positron emission mammography.
    Greene LR; George RF
    Radiol Technol; 2012; 84(1):18-30. PubMed ID: 22988260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography and ultrasonography evaluation of unexpected focal 18F-FDG uptakes in breast on PET/CT.
    Kim MY; Cho N; Chang JM; Yun BL; Bae MS; Kang KW; Moon WK
    Acta Radiol; 2012 Apr; 53(3):249-54. PubMed ID: 22262866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An amorphous selenium based positron emission mammography camera with avalanche gain.
    Reznik A; Lui BJ; Rowlands JA
    Technol Cancer Res Treat; 2005 Feb; 4(1):61-7. PubMed ID: 15649089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contrast-enhanced spectral mammography (CESM) versus breast magnetic resonance imaging (MRI): A retrospective comparison in 66 breast lesions.
    Li L; Roth R; Germaine P; Ren S; Lee M; Hunter K; Tinney E; Liao L
    Diagn Interv Imaging; 2017 Feb; 98(2):113-123. PubMed ID: 27687829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positron emission mammography in the evaluation of interim response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
    Soldevilla-Gallardo I; Villaseñor-Navarro Y; Medina-Ornelas SS; Villarreal-Garza C; Bargalló-Rocha E; Caro-Sánchez CH; Gallardo-Alvarado LN; Hernández-Ramírez R; Arela-Quispe LM; García-Pérez FO
    Cancer Treat Res Commun; 2018; 16():24-31. PubMed ID: 31298999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission mammography: high-resolution biochemical breast imaging.
    Weinberg IN; Beylin D; Zavarzin V; Yarnall S; Stepanov PY; Anashkin E; Narayanan D; Dolinsky S; Lauckner K; Adler LP
    Technol Cancer Res Treat; 2005 Feb; 4(1):55-60. PubMed ID: 15649088
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Newly Diagnosed Breast Cancer: Comparison of Contrast-enhanced Spectral Mammography and Breast MR Imaging in the Evaluation of Extent of Disease.
    Lee-Felker SA; Tekchandani L; Thomas M; Gupta E; Andrews-Tang D; Roth A; Sayre J; Rahbar G
    Radiology; 2017 Nov; 285(2):389-400. PubMed ID: 28654337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of ¹⁸F-FDG PET/MRI, ¹⁸F-FDG PET/CT, MRI, and CT in whole-body staging of recurrent breast cancer.
    Sawicki LM; Grueneisen J; Schaarschmidt BM; Buchbender C; Nagarajah J; Umutlu L; Antoch G; Kinner S
    Eur J Radiol; 2016 Feb; 85(2):459-65. PubMed ID: 26781152
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PET-guided breast biopsy.
    Kalinyak JE; Schilling K; Berg WA; Narayanan D; Mayberry JP; Rai R; Dupree EB; Shusterman DK; Gittleman MA; Luo W; Matthews CG
    Breast J; 2011; 17(2):143-51. PubMed ID: 21276128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements.
    Raylman RR; Majewski S; Smith MF; Proffitt J; Hammond W; Srinivasan A; McKisson J; Popov V; Weisenberger A; Judy CO; Kross B; Ramasubramanian S; Banta LE; Kinahan PE; Champley K
    Phys Med Biol; 2008 Feb; 53(3):637-53. PubMed ID: 18199907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Image improvement method for positron emission mammography.
    Slavine NV; Seiler SJ; McColl RW; Lenkinski RE
    Phys Med; 2017 Jul; 39():164-173. PubMed ID: 28688583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.